Molecular Biology

I.C. Hsu, R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang, C.C. Harris, "Mutational hotspot in the p53 gene in human hepatocellular carcinomas," Nature, 350:427-8, 1991. Curtis Harris (National Cancer Institute, Bethesda, Md.): "Classical epidemiology has successfully identified human populations at high cancer risk and associated the risk with exposure to environmental agents. For example, hepatitis B virus and aflatoxin B1 have been epidemiologically linked to human liver cancer. "More recen

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I.C. Hsu, R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang, C.C. Harris, "Mutational hotspot in the p53 gene in human hepatocellular carcinomas," Nature, 350:427-8, 1991.

Curtis Harris (National Cancer Institute, Bethesda, Md.): "Classical epidemiology has successfully identified human populations at high cancer risk and associated the risk with exposure to environmental agents. For example, hepatitis B virus and aflatoxin B1 have been epidemiologically linked to human liver cancer.

"More recently, molecular analysis of human cancers has identified oncogenes and tumor suppressor genes, with mutation of the p53 tumor suppressor gene the most common genetic change found in human cancer (M.C. Hollstein, et al., Science, 253:49- 53, 1991).

"Our initial questions were: Is the p53 gene mutated in human hepatocellular carcinoma; and, if so, is the mutational spectrum reflective of that caused by aflatoxin B1 in experimental mutagenesis assays? To test our hypotheses, a collaborative study was formed with colleague Zong-tang ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies